Hexicon suppositories vag 16 mg No. 10
Compound
Active substance: chlorhexidine bigluconate solution 20% 85.2 mg, which corresponds to the content of chlorhexidine bigluconate 16 mg.
Excipients: macrogol mixture (macrogol 1500, macrogol 400).
Pharmacokinetics
When administered intravaginally, it is practically not absorbed and has no systemic effect.
Indications for use
- Prevention of sexually transmitted infections (including gonorrhea, syphilis, trichomoniasis, chlamydia, ureaplasmosis, genital herpes);
- prevention of infectious and inflammatory complications in obstetrics and gynecology (before surgical treatment of gynecological diseases, before childbirth and abortion, before and after installation of an intrauterine device, before and after diathermocoagulation of the cervix, before intrauterine examinations);
- treatment of bacterial vaginosis, colpitis (including nonspecific, mixed, trichomonas).
Contraindications
Hypersensitivity to the components of the drug.
Directions for use and doses
To prevent sexually transmitted infections, 1 suppository is prescribed once. The drug should be used no later than 2 hours after sexual intercourse.
For treatment, 1 suppository is prescribed 2 times a day for 7-10 days.
Storage conditions
The drug should be stored out of the reach of children, protected from light at a temperature not exceeding 25°C.
Best before date
2 years. Do not use the drug after the expiration date indicated on the package.
special instructions
In childhood, it is recommended to use the drug Hexicon® D.
Description
Antiseptic.
Pharmacodynamics
Antiseptic drug for local use.
Active against gram-positive and gram-negative bacteria: Treponema pallidum, Chlamydia spp., Ureaplasma spp., Neisseria gonorrhoeae, Gardnerella vaginalis, Bacteroides fragilis; protozoa: Trichomonas vaginalis; viruses: Herpes simplex types 1 and 2.
Hexicon® does not interfere with the functional activity of lactobacilli.
Remains active (albeit somewhat reduced) in the presence of blood and pus.
Side effects
Possible: allergic reactions, itching, which disappear after discontinuation of the drug.
Use during pregnancy and breastfeeding
The drug is not contraindicated for use during pregnancy and lactation (breastfeeding).
Interaction
Hexicon® is not compatible with detergents containing an anionic group (saponins, sodium lauryl sulfate, sodium carboxymethylcellulose) and soaps if they are administered intravaginally. Toilet of the external genitalia does not affect the effectiveness and tolerability of Hexicon® vaginal suppositories, because the drug is used intravaginally.
Overdose
Currently, no cases of overdose of Hexicon® have been reported.
Hexicon vaginal suppositories 16 mg No. 10
A country
Russia
The country of production may vary depending on the batch of goods. Please check with the operator for detailed information when confirming your order.
Active substance
Chlorhexidine
Compound
Release form: Hexicon®, vaginal suppositories, 1 or 5 suppositories are placed in a blister pack. One contour blister pack with one suppository and two fingertips, one or two contour blister packs of 5 suppositories each, together with instructions for medical use of the drug, are placed in a cardboard pack. Composition: One suppository contains: active substance: chlorhexidine digluconate - 16 mg (chlorhexidine digluconate is used in the form of a solution (concentration 20%)); excipients: base for suppositories - a sufficient amount to obtain a suppository weighing 3.10 g - macrogol 1500 (polyethylene oxide 1500) 92 - 98%, macrogol 400 (polyethylene oxide 400) 8 - 2%. Quantity per package: 10 vaginal suppositories.
pharmachologic effect
Hexicon® is an antiseptic drug for topical use, active against protozoa, gram-positive and gram-negative bacteria, viruses, including: Treponema pallidum, Chlamidia spp., Ureaplasma spp., Neisseria gonorrhoeae, Trichomonas vaginalis, Gardnerella vaginalis, Bacteroides fragilis, Herpes virus. Some strains of Pseudomonas spp., Proteus spp. are weakly sensitive to the drug, and acid-resistant forms of bacteria, bacterial spores, and fungi are also resistant. Hexicon® does not interfere with the functional activity of lactobacilli. Remains active (albeit somewhat reduced) in the presence of blood and pus.
Indications for use
Prevention of sexually transmitted infections (chlamydia, ureaplasmosis, trichomoniasis, gonorrhea, syphilis, genital herpes, etc.). Prevention of infectious and inflammatory complications in obstetrics and gynecology (before surgical treatment of gynecological diseases, before childbirth and abortion, before and after installation of an intrauterine spirals (IUD), before and after diathermocoagulation of the cervix, before intrauterine examinations). Treatment of bacterial vaginosis, colpitis (including nonspecific, mixed, trichomonas).
Mode of application
Intravaginally. Before use, the suppository is removed from the contour packaging. For treatment: 1 suppository 2 times a day, for 7–10 days. For the prevention of sexually transmitted infections: 1 suppository no later than 2 hours after unprotected sexual intercourse.
Interaction
Simultaneous use with iodine is not recommended. Hexicon® is not compatible with detergents containing an anionic group (saponins, sodium lauryl sulfate, sodium carboxymethylcellulose) and soaps if they are administered intravaginally. Toilet of the external genitalia does not affect the effectiveness and tolerability of Hexicon® vaginal suppositories, because the drug is used intravaginally.
Side effect
Possible allergic reactions, itching, which disappear after discontinuation of the drug
Contraindications
Hypersensitivity to the components of the drug.
Hexicon® d (Hexicon d)
Manufacturer: NIZHFARM OJSC (Russia)
◊ vaginal suppositories. 8 mg: 5 or 10 pcs. Reg. No.: LS-000185
Clinical and pharmacological group:
Antiseptic for local use in gynecology
Release form, composition and packaging
◊ Vaginal suppositories
white or white with a yellowish tint, torpedo-shaped, marbling of the surface is allowed.
| 1 sup. | |
| chlorhexidine bigluconate* | 8 mg |
* chlorhexidine bigluconate is used in the form of a solution (20% concentration).
Excipients:
base for suppositories - macrogol 1500 (polyethylene oxide 1500), macrogol 400 (polyethylene oxide 400) - a sufficient amount to obtain a suppository weighing 1.5 g.
5 pieces. — cellular contour packages (1) — cardboard packs. 5 pieces. — contour cell packaging (2) — cardboard packs.
Description of the active components of the drug "Heksikon® d"
pharmachologic effect
Antiseptic drug for local use.
Active against
gram-positive and gram-negative bacteria
- Treponema pallidum, Chlamydia spp., Ureaplasma spp., Neisseria gonorrhoeae, Gardnerella vaginalis, Bacteroides fragilis;
protozoa
- Trichomonas vaginalis;
viruses
- Herpes simplex types 1 and 2.
Hexicon does not interfere with the functional activity of lactobacilli.
Remains active (albeit somewhat reduced) in the presence of blood and pus.
Indications
— prevention of sexually transmitted diseases (including gonorrhea, syphilis, trichomoniasis, chlamydia, ureaplasmosis, genital herpes);
— prevention of infectious and inflammatory complications in obstetrics and gynecology (before surgical treatment of gynecological diseases, before and after diathermocoagulation of the cervix, before intrauterine examinations);
- treatment of chronic exo- and endocervicitis, vaginitis (including nonspecific, mixed, trichomonas).
Dosage regimen
To prevent
sexually transmitted diseases,
1 soup is prescribed once. The drug should be used no later than 2 hours after sexual intercourse.
For treatment
1 soup is prescribed. 2 times/day for 7-10 days. If necessary, it is possible to extend therapy up to 20 days.
Side effect
Possible:
allergic reactions, itching, which disappear after discontinuation of the drug.
Contraindications
- hypersensitivity to the components of the drug;
- allergic reactions.
Pregnancy and lactation
The drug is not contraindicated for use during pregnancy and lactation (breastfeeding).
special instructions
In childhood, it is recommended to use the drug Hexicon D.
Overdose
Currently, no cases of overdose of Hexicon D have been reported.
Drug interactions
Hexicon D is not compatible with detergents containing an anionic group (saponins, sodium lauryl sulfate, sodium carboxymethylcellulose) and soaps. The presence of soap can inactivate chlorhexidine, so before using the drug, any remaining soap must be thoroughly rinsed off.
Conditions for dispensing from pharmacies
The drug is approved for use as a means of OTC.
Storage conditions and periods
The drug should be stored out of the reach of children, protected from light at a temperature not exceeding 25°C. Shelf life – 2 years.
Drug interactions
Hexicon D is not compatible with detergents containing an anionic group (saponins, sodium lauryl sulfate, sodium carboxymethylcellulose) and soaps. The presence of soap can inactivate chlorhexidine, so before using the drug, any remaining soap must be thoroughly rinsed off.
Hexicon D vaginal suppositories 8 mg 10 pcs
Registration Certificate Holder
NIZHFARM (Russia)
Dosage form
Medicine - Hexicon® D (Hexicon D)
Description
Vaginal suppositories
white or white with a yellowish tint, torpedo-shaped, marbling of the surface is allowed.
1 sup.
chlorhexidine bigluconate* 8 mg
* chlorhexidine bigluconate is used in the form of a solution (20% concentration).
Excipients
: base for suppositories - macrogol 1500 (polyethylene oxide 1500), macrogol 400 (polyethylene oxide 400) - a sufficient amount to obtain a suppository weighing 1.5 g.
5 pieces. — cellular contour packages (1) — cardboard packs. 5 pieces. — contour cell packaging (2) — cardboard packs.
Indications
- prevention of sexually transmitted diseases (including gonorrhea, syphilis, trichomoniasis, chlamydia, ureaplasmosis, genital herpes);
- prevention of infectious and inflammatory complications in obstetrics and gynecology (before surgical treatment of gynecological diseases, before and after diathermocoagulation of the cervix, before intrauterine examinations);
- treatment of chronic exo- and endocervicitis, vaginitis (including nonspecific, mixed, trichomonas).
Contraindications for use
- hypersensitivity to the components of the drug;
- allergic reactions.
pharmachologic effect
Antiseptic drug for local use.
Active against
gram-positive and gram-negative bacteria
- Treponema pallidum, Chlamydia spp., Ureaplasma spp., Neisseria gonorrhoeae, Gardnerella vaginalis, Bacteroides fragilis;
protozoa
- Trichomonas vaginalis;
viruses
- Herpes simplex types 1 and 2.
Hexicon does not interfere with the functional activity of lactobacilli.
Remains active (albeit somewhat reduced) in the presence of blood and pus.
Drug interactions
Hexicon D is not compatible with detergents containing an anionic group (saponins, sodium lauryl sulfate, sodium carboxymethylcellulose) and soaps. The presence of soap can inactivate chlorhexidine, so before using the drug, any remaining soap must be thoroughly rinsed off.
Dosage regimen
To prevent
sexually transmitted diseases,
1 soup is prescribed once. The drug should be used no later than 2 hours after sexual intercourse.
For treatment
1 soup is prescribed. 2 times/day for 7-10 days. If necessary, it is possible to extend therapy up to 20 days.
Overdose
Currently, no cases of overdose of Hexicon D have been reported.
Side effect
Possible:
allergic reactions, itching, which disappear after discontinuation of the drug.
special instructions
In childhood, it is recommended to use the drug Hexicon D.
Storage conditions
The drug should be stored out of the reach of children, protected from light at a temperature not exceeding 25°C.
Best before date
Shelf life – 2 years.
Use during pregnancy and breastfeeding
Restrictions during pregnancy - No restrictions. Restrictions when breastfeeding - No restrictions. The drug is not contraindicated for use during pregnancy and lactation (breastfeeding).
Use in children
Restrictions for children - No restrictions.
Terms of sale
The drug is approved for use as a means of OTC.
Contacts for inquiries
STADA (Russia)
603950 Nizhny Novgorod st. Salganskaya, 7 Tel. Fax E-mail
